DEERFIELD, Ill.--(BUSINESS WIRE)--OVATION Pharmaceuticals, Inc. announced positive results from its recent study to evaluate the safety and efficacy of clobazam in patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy. Clobazam has a unique chemical structure with associated properties when compared with other currently available benzodiazepines.
